(Q39854336)

15 September 2017

Synergistic antitumor effects of fleroxacin with 5-fluorouracil in vitro and in vivo for bladder cancer cell lines (English)

1 reference

15 September 2017

1 reference

Toru Nishikawa

1

1 reference

15 September 2017

Yasuo Kohjimoto

2

1 reference

15 September 2017

Masaya Nishihata

3

1 reference

15 September 2017

Shoichi Ebisuno

4

1 reference

15 September 2017

Isao Hara

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

9 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

74

1 reference

15 September 2017

1370-1376

1 reference

15 September 2017

6

1 reference

Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Inhibition of hepatitis C virus replication by antimonial compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Effect of fleroxacin on mouse bladder carcinogenesis with N-butyl-N- (4-hydroxybutyl) nitrosamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Antitumor activity of common antibiotics against superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Single-drug chemotherapy with 5-FU and adriamycin in metastatic bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Prophylactic oral UFT therapy for superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.03.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2009.03.006

1 reference

15 September 2017

1 reference